The deal priced below last closing price of $2.88. TD Cowen, Barclays and BTIG are acting as joint book running managers for the offering.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HUMA:
- Humacyte announces common stock offering, no amount given
- Largest borrow rate increases among liquid names
- HUMA Upcoming Earnings Report: What to Expect?
- Humacyte’s Symvess: A Transformative Solution in Vascular Trauma Care with Strong Market Potential
- Humacyte price target lowered to $7.50 from $10 at TD Cowen